Search results
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 1 year agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 4 weeks agoMerck MRK reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 4 weeks agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
Patients with incurable cervical cancer to be offered life-extending drug
The Independent UK via AOL· 1 year agoPatients with incurable cervical cancer are to be offered a new treatment which could give them more...
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
Barrons.com· 2 months agoMerck secured Food and Drug Administration approval for a drug widely expected to be an era-defining...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 4 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 3 weeks agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Column: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's...
LA Times via Yahoo Finance· 11 months agoThe big drugmaker Merck wants to stifle Medicare's right to negotiate drug prices. (Mel Evans /...
Merck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts Sales
Zacks via Yahoo Finance· 7 months agoMerck MRK reported adjusted earnings of $2.13 per share for third-quarter 2023, beating the Zacks...